Levofloxacin in pharma franchise in Sikkim

Levofloxacin in PCD pharma franchise in Agartala

Levofloxacin in top pharma company in Jabalpur

Levofloxacin in pcd pharma supplier in Ranchi

Levofloxacin in phama franchise company in India
Levofloxacin in phama distributor in Howrah

Home/Products /levofloxacin-750mg-tablet

Lexoziff 750 Tablet

Composition : Levofloxacin (750mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹130/-

Lexoziff 750 Tablet is a broad-spectrum antibiotic containing Levofloxacin, a fluoroquinolone antibiotic that effectively targets and kills a wide range of harmful bacteria. It works by inhibiting bacterial enzymes essential for DNA replication, thus preventing bacterial growth and spread. This action helps treat and manage various bacterial infections effectively.

Lexoziff 750 is primarily used for treating serious bacterial infections, including pneumonia, urinary tract infections (UTIs), skin and soft tissue infections, and intra-abdominal infections. It is also effective in managing acute exacerbations of chronic bronchitis and infections associated with chronic obstructive pulmonary disease (COPD). The high-dose formulation of 750mg ensures effective treatment for severe and complicated infections, providing significant relief for patients. The medication's once-daily dosing regimen increases convenience, improving patient adherence to prescribed therapy.

This combination of high potency and broad-spectrum activity makes Lexoziff 750 a versatile choice in the treatment of bacterial infections. It is particularly beneficial in cases where other antibiotics may have failed or where more robust treatment is needed.

Read More

About the Product

Lexoziff 750 Tablet is a broad-spectrum antibiotic containing Levofloxacin, a fluoroquinolone antibiotic that effectively targets and kills a wide range of harmful bacteria. It works by inhibiting bacterial enzymes essential for DNA replication, thus preventing bacterial growth and spread. This action helps treat and manage various bacterial infections effectively.

Lexoziff 750 is primarily used for treating serious bacterial infections, including pneumonia, urinary tract infections (UTIs), skin and soft tissue infections, and intra-abdominal infections. It is also effective in managing acute exacerbations of chronic bronchitis and infections associated with chronic obstructive pulmonary disease (COPD). The high-dose formulation of 750mg ensures effective treatment for severe and complicated infections, providing significant relief for patients. The medication's once-daily dosing regimen increases convenience, improving patient adherence to prescribed therapy.

This combination of high potency and broad-spectrum activity makes Lexoziff 750 a versatile choice in the treatment of bacterial infections. It is particularly beneficial in cases where other antibiotics may have failed or where more robust treatment is needed.

Common side effects may include nausea, diarrhea, dizziness, headache, and insomnia. Serious side effects such as tendonitis or tendon rupture are rare but possible.

Lexoziff 750 Tablet is indicated for the treatment of severe bacterial infections including pneumonia, urinary tract infections, skin and soft tissue infections, and acute exacerbations of chronic bronchitis.

Do not use if allergic to Levofloxacin or any other fluoroquinolone antibiotics. Consult a healthcare provider before use if pregnant, breastfeeding, or suffering from kidney or liver disease.

Store in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation